U.S. markets closed
  • S&P 500

    3,662.45
    +40.82 (+1.13%)
     
  • Dow 30

    29,823.92
    +185.28 (+0.63%)
     
  • Nasdaq

    12,355.11
    +156.37 (+1.28%)
     
  • Russell 2000

    1,836.05
    +16.23 (+0.89%)
     
  • Crude Oil

    44.55
    -0.79 (-1.74%)
     
  • Gold

    1,818.30
    +37.40 (+2.10%)
     
  • Silver

    24.12
    +1.53 (+6.76%)
     
  • EUR/USD

    1.2074
    +0.0140 (+1.17%)
     
  • 10-Yr Bond

    0.9340
    +0.0900 (+10.66%)
     
  • GBP/USD

    1.3424
    +0.0093 (+0.70%)
     
  • USD/JPY

    104.3370
    +0.0130 (+0.01%)
     
  • BTC-USD

    19,137.04
    -262.72 (-1.35%)
     
  • CMC Crypto 200

    375.31
    -4.55 (-1.20%)
     
  • FTSE 100

    6,384.73
    +118.54 (+1.89%)
     
  • Nikkei 225

    26,787.54
    +353.92 (+1.34%)
     

Amphastar Pharmaceuticals's Earnings: A Preview

Benzinga Insights
·1 min read

On Thursday, August 06, Amphastar Pharmaceuticals (NASDAQ: AMPH) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release.

Earnings and Revenue

Analysts expect Amphastar Pharmaceuticals earnings of $0.14 per share. Revenue will likely be around $86.62 million, according to the consensus estimate. In the same quarter last year, Amphastar Pharmaceuticals reported EPS of $0.080 on revenue of $79.05 million. If the company were to match the consensus estimate, earnings would be up 75.0%. Amphastar Pharmaceuticals's reported EPS has stacked up against analyst estimates in the past like this:

Quarter

Q1 2020

Q4 2020

Q3 2019

Q2 2019

EPS Estimate

0.08

0.07

0.07

0.03

EPS Actual

0.17

0.07

0.10

0.08

Revenue Estimate

82.83 M

81.79 M

78.53 M

77.61 M

Revenue Actual

84.69 M

83.38 M

80.14 M

79.05 M

Stock Performance

Over the last 52-week period, shares are down 1.19%. Given that these returns are generally negative, long-term shareholders are probably down going into this earnings release.

View more earnings on AMPH

Don't be surprised to see the stock move on comments made during its conference call. Amphastar Pharmaceuticals is scheduled to hold the call at 17:00:00 ET and can be accessed here: https://edge.media-server.com/mmc/p/h94bi5cq

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.